These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 38475368)
1. Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach. Bakhrushina EO; Mikhel IB; Kondratieva VM; Zubareva IM; Kosenkova SI; Belyatskaya AV; Stepanova OI; Krasnyuk II; Grebennikova TV; Krasnyuk II Polymers (Basel); 2024 Mar; 16(5):. PubMed ID: 38475368 [TBL] [Abstract][Full Text] [Related]
2. Recent opportunities and application of gellan gum based drug delivery system for intranasal route. Garg A; Lavania K Daru; 2024 Oct; ():. PubMed ID: 39361194 [TBL] [Abstract][Full Text] [Related]
3. Main Aspects of Pharmaceutical Development of Bakhrushina E; Mikhel I; Kondratieva V; Demina N; Grebennikova T; Krasnyuk I; Krasnyuk I Curr Pharm Biotechnol; 2024; 25(11):1394-1405. PubMed ID: 37842893 [TBL] [Abstract][Full Text] [Related]
4. QbD Assisted Development of a Compartment and Sequential Drug Delivery System for Periodontotherapy. Jain P; Iqbal Z Comb Chem High Throughput Screen; 2024 May; ():. PubMed ID: 38752641 [TBL] [Abstract][Full Text] [Related]
5. Implementation of quality by design principles in the development of microsponges as drug delivery carriers: Identification and optimization of critical factors using multivariate statistical analyses and design of experiments studies. Simonoska Crcarevska M; Dimitrovska A; Sibinovska N; Mladenovska K; Slavevska Raicki R; Glavas Dodov M Int J Pharm; 2015 Jul; 489(1-2):58-72. PubMed ID: 25895722 [TBL] [Abstract][Full Text] [Related]
6. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226 [TBL] [Abstract][Full Text] [Related]
7. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration. Salunke SR; Patil SB Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173 [TBL] [Abstract][Full Text] [Related]
8. Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems. Mohseni-Motlagh SF; Dolatabadi R; Baniassadi M; Baghani M Polymers (Basel); 2023 Nov; 15(22):. PubMed ID: 38006131 [TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524 [TBL] [Abstract][Full Text] [Related]
10. Formulation and Evaluation of in situ Gels Containing Clotrimazole for Oral Candidiasis. Harish NM; Prabhu P; Charyulu RN; Gulzar MA; Subrahmanyam EV Indian J Pharm Sci; 2009 Jul; 71(4):421-7. PubMed ID: 20502548 [TBL] [Abstract][Full Text] [Related]
11. Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide. Morsi N; Ibrahim M; Refai H; El Sorogy H Eur J Pharm Sci; 2017 Jun; 104():302-314. PubMed ID: 28433750 [TBL] [Abstract][Full Text] [Related]
12. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Cao SL; Ren XW; Zhang QZ; Chen E; Xu F; Chen J; Liu LC; Jiang XG Int J Pharm; 2009 Jan; 365(1-2):109-15. PubMed ID: 18822361 [TBL] [Abstract][Full Text] [Related]
13. Nose-to-brain delivery of drug nanocrystals by using Ca Huang G; Xie J; Shuai S; Wei S; Chen Y; Guan Z; Zheng Q; Yue P; Wang C Int J Pharm; 2021 Feb; 594():120182. PubMed ID: 33346126 [TBL] [Abstract][Full Text] [Related]
14. Ion-Triggered In Situ Gelling Intranasal Spray of Dronedarone Hydrochloride Nanocarriers: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal. Teaima MH; Helal DA; Alsofany JM; El-Nabarawi MA; Yasser M Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365223 [TBL] [Abstract][Full Text] [Related]
15. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine. Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794 [TBL] [Abstract][Full Text] [Related]
16. Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies. Gadhave D; Rasal N; Sonawane R; Sekar M; Kokare C Int J Biol Macromol; 2021 Jan; 167():906-920. PubMed ID: 33186648 [TBL] [Abstract][Full Text] [Related]
17. Elmowafy E; Cespi M; Bonacucina G; Soliman ME Pharm Dev Technol; 2019 Dec; 24(10):1258-1271. PubMed ID: 31437077 [TBL] [Abstract][Full Text] [Related]
18. A novel in situ gel formulation of ranitidine for oral sustained delivery. Xu H; Shi M; Liu Y; Jiang J; Ma T Biomol Ther (Seoul); 2014 Feb; 22(2):161-5. PubMed ID: 24753823 [TBL] [Abstract][Full Text] [Related]
19. Quality by design-based optimization of in situ ionic-sensitive gels of amoxicillin-loaded bovine serum albumin nanoparticles for enhanced local nasal delivery. Mardikasari SA; Katona G; Budai-Szűcs M; Sipos B; Orosz L; Burián K; Rovó L; Csóka I Int J Pharm; 2023 Oct; 645():123435. PubMed ID: 37741560 [TBL] [Abstract][Full Text] [Related]
20. Quality by Design approach for an in situ gelling microemulsion of Lorazepam via intranasal route. Shah V; Sharma M; Pandya R; Parikh RK; Bharatiya B; Shukla A; Tsai HC Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1231-1241. PubMed ID: 28415411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]